Literature DB >> 27460848

Effect of uterine contractions on fetal heart rate in pregnancy: a prospective observational study.

Julie Sletten1, Torvid Kiserud1,2, Jörg Kessler3,4.   

Abstract

INTRODUCTION: The new Holter monitoring technology enables long-term electrocardiographic recording of the fetal heart rate without discomfort for the mother. The aim of the study was to assess the feasibility of a fetal Holter monitor. This technology was further used to study fetal heart rate outside the hospital setting during normal daily activities and to test the hypothesis that uterine activity during pregnancy influences fetal heart rate.
MATERIAL AND METHODS: Prospective observational study including 12 healthy pregnant women at 20-40 weeks of gestation. Data were collected using the Monica AN24 system. Outcome measures were fetal heart rate, maternal heart rate, and uterine activity categorized according to the strength of the electrohysterographic signal.
RESULTS: The recordings had a median length of 18.8 h, and fetal heart rate and maternal heart rate were obtained with success rates of 73.1 and 99.9%, respectively. Uterine activity was found to affect fetal heart rate in all participants. Compared with the basal tone and mild levels of uterine activity, moderate and strong levels of uterine activity were associated with increases in fetal heart rate of 4.0 and 5.7 beats/min, respectively. At night, the corresponding increases were 4.9 and 7.6 beats/min. Linear correlations were found between maternal heart rate and fetal heart rate in 11 of the 12 cases, with a mean coefficient beta of 0.189. Both maternal heart rate and fetal heart rate exhibited a diurnal pattern, with lower heart rates being recorded at night.
CONCLUSIONS: Uterine activity during pregnancy is associated with a graded response in fetal heart rate and may represent a physiological challenge for the development and adaptation of the fetal cardiovascular system.
© 2016 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Fetal heart rate; electrohysterography; fetal Holter monitor; maternal heart rate; uterine contraction

Mesh:

Year:  2016        PMID: 27460848     DOI: 10.1111/aogs.12949

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

1.  DISCOVERING CAUSALITIES FROM CARDIOTOCOGRAPHY SIGNALS USING IMPROVED CONVERGENT CROSS MAPPING WITH GAUSSIAN PROCESSES.

Authors:  Guanchao Feng; J Gerald Quirk; Petar M Djurić
Journal:  Proc IEEE Int Conf Acoust Speech Signal Process       Date:  2020-05-14

2.  Detecting Causality using Deep Gaussian Processes.

Authors:  Guanchao Feng; J Gerald Quirk; Petar M Djurić
Journal:  Conf Rec Asilomar Conf Signals Syst Comput       Date:  2020-03-30

3.  A systematic scoping review to identify the design and assess the performance of devices for antenatal continuous fetal monitoring.

Authors:  Kajal K Tamber; Dexter J L Hayes; Stephen J Carey; Jayawan H B Wijekoon; Alexander E P Heazell
Journal:  PLoS One       Date:  2020-12-01       Impact factor: 3.240

4.  INFERENCE ABOUT CAUSALITY FROM CARDIOTOCOGRAPHY SIGNALS USING GAUSSIAN PROCESSES.

Authors:  Guanchao Feng; J Gerald Quirk; Petar M Djurić
Journal:  Proc IEEE Int Conf Acoust Speech Signal Process       Date:  2019-04-17

5.  Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?

Authors:  Gal Cohen; Maya Shavit; Netanella Miller; Rimon Moran; Yael Yagur; Omer Weitzner; Michal Ovadia; Hanoch Schreiber; Gil Shechter-Maor; Tal Biron-Shental
Journal:  PLoS One       Date:  2022-05-12       Impact factor: 3.752

6.  Proportion and Associated Factors of Nonreassuring Fetal Heart Rate Patterns in Finote Selam Primary Hospital, North West Ethiopia.

Authors:  Eden Asmare Kassahun; Amlaku Mulat Aweke; Almaz Aklilu Getu; Getahun Belay Gela; Simachew Kassa Limenih; Mesafint Ewnetu Mekonnen; Tilksew Ayalew Abtie
Journal:  Biomed Res Int       Date:  2020-09-19       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.